1. Dear Drugs-Forum readers: We are a small non-profit that runs one of the most read drug information & addiction help websites in the world. We serve over 4 million readers per month, and have costs like all popular websites: servers, hosting, licenses and software. To protect our independence we do not run ads. We take no government funds. We run on donations which average $25. If everyone reading this would donate $5 then this fund raiser would be done in an hour. If Drugs-Forum is useful to you, take one minute to keep it online another year by donating whatever you can today. Donations are currently not sufficient to pay our bills and keep the site up. Your help is most welcome. Thank you.
    PLEASE HELP
  1. RoboCop
    There was recently a new Salvinorin A analog made that is seven times as potent as Salvinorin A. Here is a small article on it.

    Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues

    David Y.W. Leea, Vishnu V.R. Karnatia, Minsheng Hea, Lee-Yuan Liu-Chenb, Leelakrishna Kondaretia, Zhongze Maa, Yulin Wangb, Yong Chenb, Cecile Beguind, William A. Carlezon, Jr.c and Bruce Cohend, ,

    aBioorganic and Natural Products Laboratory, McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA
    bDepartment of Pharmacology, School of Medicine, Temple University, 3420 N. Broad St, Philadelphia, PA 19140, USA
    cBehavioral Genetics Laboratory, McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA
    dMolecular Pharmacology Laboratory, McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA

    Received 18 March 2005; revised 16 May 2005; accepted 17 May 2005. Available online 1 July 2005.




    Abstract
    Salvinorin A is the most potent naturally occurring opioid agonist yet discovered with high selectivity and affinity for ê-opioid receptor. To explore its structure and activity relationships, a series of salvinorin A derivatives modified at the C(2) position were prepared and studied. These salvinorin A derivatives were screened for binding and functional activities at the human ê-opioid receptor. Compound 4, containing a methoxymethyl group at the 2-position, was a full ê-agonist with an EC50 value at 0.6 nM, which is about 7 times more potent than salvinorin A.


    Graphical abstract
    A series of salvinorin A derivatives modified at the C(2) position were prepared and screened for binding and functional activities at the human ê-opioid receptor. A highly selective ê-agonist (EC50 = 0.6 nM) was identified.



    Keywords: ê Opioid-receptor; Salvinorin A; Diterpenoid; Agonist; Binding activity

Comments

  1. Montgolfier
    I cant imagine what the effects would be from a substance 7 times more potent than Salvinorin A! - I think I'd let my mate go first [​IMG]
  2. D.U.M.B
    ^ LOL

    But seriously I guess this is pretty good news
  3. anj0vis
    interesting to say the least.. i wonder if it has better bio-availability orally.. that would be quite interesting compound then. Although i can easily see "salvia on blotters" signs here and soon they would be banned.
To make a comment simply sign up and become a member!